MedPath

Magnetometer guided sentinel lymphadenectomy after marking with superparamagnetic iron oxide nanoparticles versus extended lymphadenectomy in prostate cancer: rate of detection and sensitivity in compariso

Not Applicable
Conditions
C61
Malignant neoplasm of prostate
Registration Number
DRKS00007671
Lead Sponsor
niversitätsklinik für Urologie, Klinikum Oldenburg, Fakultät für Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universität Oldenburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
50
Inclusion Criteria

intermediate or high risk Prostate cancer: PSA greater than 10 and/or Gleason score graeter or equal to 7

Exclusion Criteria

Intolerance / hypersensitivity to iron or dextran or Sienna +, patients with iron overload disease, cardiac pacemakers or other in the chest wall implanted devices, patients with hip prostheses or other metallic implants in the pelvic area, patients with previous surgery on the prostate (eg transurethral prostate resection, adenomectomy, laser enucleation); patient, who are not capable of giving consent

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath